Clinical Trial Update: Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL) [Phase 3]

View source ↗

Summary

This Phase 3 trial update describes a study of Sonrotoclax (BGB-11417) plus Zanubrutinib (BGB-3111) versus Venetoclax plus Obinutuzumab in chronic lymphocytic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)
• Gazyva (Obinutuzumab)
• Sonrotoclax
• Venclexta (venetoclax)

Snippet

Sponsor: BeOne Medicines | Conditions: CLL | Phase 3 | Status: ACTIVE_NOT_RECRUITING